About Us
Groundbreaking Science
NavIntus' groundbreaking DNA-base drug delivery research works by repressing the Nav1.7 pain sensing gene which will allow for increased human pain tolerance and a decrease in pain sensitivity, providing months of pain relief without causing numbness.
Opioid Crisis
Drug overdose deaths rose by close to 30% in the United States in 2020, hitting the highest number ever recorded…Nearly 70,000 people in the U.S. died from opioid-involved overdoses. (Source: CDC, July 2021)
Promise of Advancement in Pain Management
NavIntus is developing alternative systems to deliver the genetic code of Nav1.7 repressor into the cell needed to block pain sensation.
